NCT00741988 2021-12-15
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
SCRI Development Innovations, LLC
R-Pharm
Masonic Cancer Center, University of Minnesota
Providence Health & Services
UNC Lineberger Comprehensive Cancer Center